Clinical Trial Update: rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A

View source ↗

Summary

This document reports a completed chart review study assessing immune tolerance induction using rFVIIIFc (Elocta) in patients with Hemophilia A with inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• Elocta (efmoroctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A With Inhibitor | Status: COMPLETED